### Clinical Findings for Variant rs431905511

#### 1. **Variant Identification**
- **rs Number**: [rs431905511](https://identifiers.org/dbsnp/rs431905511)
- **HGVS Notation**:
  - Genomic: `chr4:g.89828154C>T`
  - Transcript: Multiple transcripts are affected, including:
    - `ENST00000336904.7:c.152G>A` (Protein: `p.Gly51Asp`)
    - `NM_000345.4:c.152G>A` (Protein: `p.Gly51Asp`)
- **Gene**: **SNCA** (Synuclein Alpha)
- **Transcript**: Multiple transcripts are affected, including **ENST00000336904** and **NM_000345.4**.

#### 2. **Disease Associations**
- **Condition**: Autosomal Dominant Parkinson Disease 1 (MedGen ID: [C1868595](https://www.ncbi.nlm.nih.gov/medgen/C1868595))
- **Clinical Significance**: Pathogenic (P) according to ClinVar ([ClinVar Entry](https://www.ncbi.nlm.nih.gov/clinvar/variation/97000)).
- **Functional Impact**:
  - **SIFT**: 0.03 (Deleterious)
  - **PolyPhen-2**: 0.996 (Probably Damaging)
  - **AlphaMissense**: 0.7612 (High likelihood of pathogenicity)

#### 3. **Literature Evidence**
- The variant has been associated with **Parkinson's disease** in multiple studies. However, no specific publications were retrieved directly from the TogoVar API. Based on external knowledge, the **p.Gly51Asp** mutation in the SNCA gene is a well-documented pathogenic variant linked to early-onset Parkinson's disease.

#### 4. **Allele Frequency Comparison**
- **No allele frequency data** is available for this variant in the TogoVar database. This suggests it may be a rare or private mutation.

#### 5. **GWAS Findings**
- No genome-wide association studies (GWAS) findings are directly linked to this variant in the TogoVar database.

#### 6. **TogoVar Link**
- [TogoVar Entry for rs431905511](https://togovar.org/variant/rs431905511)

---

### Summary in English
The rs431905511 variant in the **SNCA** gene is a pathogenic mutation associated with **autosomal dominant Parkinson's disease**. It results in the amino acid substitution **p.Gly51Asp**, which is predicted to be deleterious by computational tools like SIFT and PolyPhen-2. This variant is rare, with no population frequency data available, and has been linked to early-onset Parkinson's disease in clinical studies.

---

### 日本語での要約
**rs431905511**は、**SNCA**遺伝子における病原性変異であり、**常染色体優性パーキンソン病**と関連しています。この変異はアミノ酸置換**p.Gly51Asp**を引き起こし、SIFTやPolyPhen-2などの計算ツールによって有害であると予測されています。この変異は稀であり、集団頻度データは存在しませんが、臨床研究では早発型パーキンソン病との関連が示されています。

---

If you have further questions or need additional details, feel free to ask!